Startup data
| Country | |
|---|---|
| Investment Received | |
| Revenues | |
| Scope | |
| Startup stage | |
| Tecnhologies | |
| Verticals |
Embryoxite
€0,00
Description: A more effective system for embryo selection that is based on the convergence of patient clinical data, genetic diagnosis, embryo growth imaging, and the core of our startup: metabolomic diagnosis. Since 2015 our scientific team has been studying embryo metabolism. We have been developing a new disruptive diagnostic and a more accurate predictive implantation score that the professionals will use to decide which embryo will be transferred with more precision. This innovative embryo selection would increase by approximately 75% of pregnancy success.
